chr2-188995074-G-C
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000090.4(COL3A1):c.1484G>C(p.Gly495Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G495E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000090.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
- Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polymicrogyria with or without vascular-type Ehlers-Danlos syndromeInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL3A1 | ENST00000304636.9 | c.1484G>C | p.Gly495Ala | missense_variant | Exon 21 of 51 | 1 | NM_000090.4 | ENSP00000304408.4 | ||
| COL3A1 | ENST00000450867.2 | c.1385G>C | p.Gly462Ala | missense_variant | Exon 20 of 50 | 1 | ENSP00000415346.2 | |||
| COL3A1 | ENST00000713745.1 | c.1484G>C | p.Gly495Ala | missense_variant | Exon 21 of 49 | ENSP00000519049.1 | ||||
| COL3A1 | ENST00000713744.1 | c.1484G>C | p.Gly495Ala | missense_variant | Exon 21 of 49 | ENSP00000519048.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The G495A variant in the COL3A1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The G495A variant is not observed in large population cohorts (Lek et al., 2016). The G495A variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this variant results in substitution of a Glycine residue in the Gly-X-Y repetitive motif of the triple helical region of the COL3A1 gene. In this domain, the Glycine in the triplet repeat is critical for protein folding, and substitution of a triplet Glycine is a known pathogenic mechanism (Stenson et al., 2014). In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Missense variants in nearby residues (G492R, G492E, G492V, G498D) have been reported in the Human Gene Mutation Database in association with Ehlers-Danlos syndrome IV (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret G495A as a likely pathogenic variant that may explain the pes planus reported in this individual. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at